The Hyperglycemia and Adverse Pregnancy Outcome StudyDiabetes Care - Tập 35 Số 4 - Trang 780-786 - 2012
Patrick M. Catalano, David McIntyre, J. CRUICKSHANK, David R. McCance, Alan Dyer, Boyd E. Metzger, Lynn P. Lowe, Elisabeth R. Trimble, Donald R. Coustan, Bengt Persson, Moshe Hod, Jeremy Oats
OBJECTIVE To determine associations of gestational diabetes mellitus (GDM) and
obesity with adverse pregnancy outcomes in the Hyperglycemia and Adverse
Pregnancy Outcome (HAPO) Study. RESEARCH DESIGN AND METHODS Participants
underwent a 75-g oral glucose tolerance test (OGTT) between 24 and 32 weeks. GDM
was diagnosed post hoc using International Association of Diabetes and Pregnancy
Study Groups ... hiện toàn bộ
Clinical, Autoimmune, and Genetic Characteristics of Adult-Onset Diabetic Patients With GAD Autoantibodies in Japan (Ehime Study)Diabetes Care - Tập 25 Số 6 - Trang 995-1001 - 2002
Haruyo Takeda, Eiji Kawasaki, Ikki Shimizu, Etsushi Konoue, Masao Fujiyama, Satoshi Murao, Kiyonobu TANAKA, Kennichi Mori, Yoshinao Tarumi, Isamu Seto, Yasuhisa Fujii, Kenichi Kato, Shiori Kondo, Yasuharu Takada, Nobuaki Kitsuki, Yukikazu Kaino, Kaichi Kida, Naotake Hashimoto, Yukio Yamane, Takashi Yamawaki, Hiroshi Onuma, Tatsuya Nishimiya, Haruhiko Osawa, Yasushi Saitō, Hideichi Makino
OBJECTIVE—To characterize the clinical, autoimmune, and genetic features in
Japanese adult-onset diabetic patients with GAD autoantibodies. RESEARCH DESIGN
AND METHODS—GAD autoantibodies (GADab) were screened in 4,980 diabetic patients
with age of onset >20 years in the hospital-based Ehime Study, and the
GADab-positive (GADab+) patients were then divided into two groups according to
their insu... hiện toàn bộ
Immunogenetic and Clinical Characterization of Slowly Progressive IDDMDiabetes Care - Tập 16 Số 5 - Trang 780-788 - 1993
Tetsuro Kobayashi, Koji Tamemoto, Kōji Nakanishi, Norihiro Kato, Minoru Okubo, Hiroshi Kajio, Tadao Sugimoto, Toshio Murase, Kinori Kosáka
OBJECTIVE To examine the clinical and immunogenetic heterogeneity of IDDM.
RESEARCH DESIGN AND METHODS We divided 207 IDDM patients into groups based on
the interval from clinical onset to initiation of insulin therapy: group A
(<3 mo, acute clinical-onset group, n = 134), group B (3–12 mo, intermediate
group, n = 31), and group C (>13 mo, slowly progressive group, n = 42).
Immunogenetic and... hiện toàn bộ
Distinct Genetic and Immunological Features in Patients With Onset of IDDM Before and After Age 40Diabetes Care - Tập 20 Số 4 - Trang 524-529 - 1997
Tobias Lohmann, Jochen Sessler, Hans-Joachim Verlohren, Sabine Schröder, Julia Rötger, Karsten Dãhn, Nils G. Morgenthaler, Werner A. Scherbaum
OBJECTIVE Young age at onset is a relevant parameter associated with a rapid
progression of IDDM. Our major aim was to define differences between IDDM
patients with age at diagnosis > 40 years and adult IDDM with onset at a
younger age. RESEARCH DESIGN AND METHODS The correlation between islet-related
antibodies (islet cell antibodies [ICAs] and antibodies [Abs] to GAD and the
tyrosine phosphat... hiện toàn bộ
GAD Antibodies in NIDDM: Ten-year follow-up from the diagnosisDiabetes Care - Tập 18 Số 12 - Trang 1557-1565 - 1995
Leo Niskanen, Jaakko Tuomilehto, Jukka Karjalainen, Leif Groop, Matti Uusitupa
OBJECTIVE To study the frequency of antibodies to glutamic acid decarboxylase
(GAD) and islet cell antibodies (ICAs) and their predictive value with respect
to the development of insulin deficiency in 133 newly diagnosed middle-aged
patients with non-insulin-dependent diabetes mellitus (NIDDM) and in 126 control
subjects and to study the persistence of GAD antibodies in diabetic patients
during th... hiện toàn bộ